Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
HPV16 immunity is different during progressive cervical intraepithelial neoplasia
January 5th, 2006
Human papillomavirus-16 immunity is significantly different during progressive cervical intraepithelial neoplasia. According to recent research published in the British Journal of Cancer, "Infection with high-risk genital human papillomavirus (HPV) types is a major risk factor for the development of cervical intraepithelial neoplasia (CIN) and invasive cervical carcinoma." "The design of effective immunotherapies requires a greater understanding of how HPV-specific T-cell responses are involved in disease clearance and/or progression." J.C. Steele and colleagues at the University of Birmingham wrote, "We have investigated...
Source: Women's Health Weekly (2006-01-05)
|
